Advise the patient to read the FDA-approved patient labeling (Instructions for Use).
Sulfonamide Reactions
Dorzolamide Hydrochloride Ophthalmic Solution is a sulfonamide and although administered topically is absorbed systemically. Therefore the same types of adverse reactions that are attributable to sulfonamides may occur with topical administration. Advise patients that if serious or unusual reactions including severe skin reactions or signs of hypersensitivity occur, they should discontinue the use of the product [see Warnings and Precautions (5.1)].
Intercurrent Ocular Conditions
Advise patients that if they have ocular surgery or develop an intercurrent ocular condition (e.g., trauma or infection), they should immediately seek their physician's advice concerning the continued use of the present multidose container.
Handling Ophthalmic Solutions
Instruct patients to avoid allowing the tip of the dispensing container to contact the eye or surrounding structures. Instruct patients that ocular solutions, if handled improperly or if the tip of the dispensing container contacts the eye or surrounding structures, can become. contaminated by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.
Concomitant Topical Ocular Therapy
If more than one topical ophthalmic drug is being used, the drugs should be administered at least five minutes apart.
Contact Lens Use
Advise patients that Dorzolamide Hydrochloride Ophthalmic Solution contains benzalkonium chloride which may be absorbed by soft contactlenses. Contact lenses should be removed prior to administration of the solution. Lenses may be reinserted 15 minutes following DorzolamideHydrochloride Ophthalmic Solution administration.
When to Seek Physician Advice
Advise patients that if they develop any ocular reactions, particularly conjunctivitis and lid reactions, they should discontinue use and seek their physician's advice.
Manufactured By:
FDC Limited
B-8, MIDC Industrial Area,
Waluj, Aurangabad 431 136, Maharashtra
India.
Distributed by:
Leading Pharma, LLC.
Fairfield, NJ07004
Revised: December 2021